Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No pharmaceutical industry blackout

Executive Summary

Pharmaceutical companies maintained "critical" business operations during a blackout affecting parts of the Northeast and Midwest on Aug. 14 and 15. Pfizer said it implemented its "snow day" plan, meaning only "critical users" reported to the company's R&D headquarters in Groton, Conn. and an Ann Arbor, Mich. facility. Diesel generators supplied power to both facilities, keeping critical manufacturing and "temperature specific" experiments operational. Pfizer's Manhattan headquarters was closed Aug. 15. Novartis and Roche, both with U.S. operations headquartered in New Jersey, said R&D and manufacturing maintained "full capacity" both days. Merck and Schering-Plough both said their New Jersey facilities were not affected by the power outages...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel